Med-Chemist : "Quintessential Medicinal Chemistry"
Wednesday, September 4, 2024
FDA Approves Fruzaqla (fruquintinib) for Previously Treated Metastatic Colorectal Cancer
›
Takeda announced the U.S. Food and Drug Administration (FDA) has approval of Fruzaqla™ (fruquintinib), an oral targeted therapy for adults ...
Tuesday, September 3, 2024
Fruquintinib + Paclitaxel Aids Advanced Gastric/Gastroesophageal Junction Cancer
›
For patients with advanced gastric or gastroesophageal junction (G/GEJ) adenocarcinoma who experienced disease progression on first-line che...
Monday, September 2, 2024
Cefepime-Taniborbactam Superior to Meropenem for Complicated UTI
›
For adults with complicated urinary tract infection (UTI), including acute pyelonephritis, cefepime-taniborbactam is superior to meropenem, ...
Friday, August 30, 2024
Drug That Treats Cocaine Addiction May Curb Colon Cancer
›
A drug first developed to treat cocaine addiction might also help slow the spread of advanced colon cancer, a new study suggests. The drug v...
Thursday, August 29, 2024
Drug Used to Treat Rheumatoid Arthritis May Also Help Prevent It
›
A clinical trial showed that the drug abatacept (Orencia) – which is already used to treat diagnosed rheumatoid arthritis – also can preve...
Wednesday, August 28, 2024
FDA Approves Aurlumyn (iloprost) as the First Medication to Treat Severe Frostbite
›
The U.S. Food and Drug Administration approved Aurlumyn (iloprost) injection to treat severe frostbite in adults to reduce the risk of finge...
Tuesday, August 27, 2024
Chugai files for additional indication of Evrysdi for pre-symptomatic SMA and additional dosage for infants up to 2 months of age
›
Chugai Pharmaceutical Co., Ltd. announced that it filed regulatory application with the Ministry of Health, Labour and Welfare (MHLW) of “Ev...
Monday, August 26, 2024
Tapinarof Cream Under FDA Review for Atopic Dermatitis Indication | MDedge Dermatology
›
Dermavant Sciences announced the company's submission of supplemental New Drug Application (sNDA) to the Food and Drug Administration...
Saturday, August 24, 2024
FDA approves tepotinib for metastatic non-small cell lung cancer | FDA
›
FDA approves tepotinib for metastatic non-small cell lung cancer On February 15, 2024, the Food and Drug Administration granted traditional ...
Friday, August 23, 2024
UCLA-led research results in FDA approval of 4-drug combination for frontline treatment of metastatic pancreatic cancer
›
A four-drug chemotherapy regimen of irinotecan liposome (Onivyde) in combination with oxaliplatin, leucovorin, and fluorouracil—together ref...
Thursday, August 22, 2024
New treatment for a rare and aggressive cancer improves survival rates in breakthrough clinical trial
›
An innovative treatment significantly increases the survival of people with malignant mesothelioma, a rare but rapidly fatal type of cancer ...
Wednesday, August 21, 2024
Ipsen’s Onivyde Regimen, a Potential New Standard-of-Care First-Line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA
›
Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug ap...
Friday, August 16, 2024
Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
›
Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) a rare disease therapeutics company, today announced it resubmitted its New Drug Application (NDA)...
Thursday, August 15, 2024
Zealand Pharma Submits New Drug Application to the US FDA for Glepaglutide in Short Bowel Syndrome
›
Zealand Pharma A/S announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for glepaglutide, ...
Wednesday, August 14, 2024
Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea
›
Journey Medical Corporation, announced that the Company has submitted, a New Drug Application (“NDA”) to the FDA seeking approval for DFD-...
‹
›
Home
View web version